NDC 71288-108

Cytarabine

Cytarabine

Cytarabine is a Intrathecal; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Cytarabine.

Product ID71288-108_ba035466-3b01-4e2b-abf5-d876619a2674
NDC71288-108
Product TypeHuman Prescription Drug
Proprietary NameCytarabine
Generic NameCytarabine
Dosage FormInjection, Solution
Route of AdministrationINTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2020-06-26
Marketing CategoryANDA / ANDA
Application NumberANDA206189
Labeler NameMeitheal Pharmaceuticals Inc.
Substance NameCYTARABINE
Active Ingredient Strength20 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71288-108-06

5 VIAL, SINGLE-DOSE in 1 CARTON (71288-108-06) > 5 mL in 1 VIAL, SINGLE-DOSE (71288-108-05)
Marketing Start Date2020-06-26
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cytarabine" or generic name "Cytarabine"

NDCBrand NameGeneric Name
61703-303CYTARABINECYTARABINE
61703-304CytarabineCYTARABINE
61703-305CytarabineCYTARABINE
61703-319CytarabineCYTARABINE
63323-120CytarabineCYTARABINE
67457-452CytarabineCytarabine
67457-454CytarabineCytarabine
67457-455cytarabinecytarabine
68083-337CytarabineCytarabine
68083-343CytarabineCytarabine
71288-108CytarabineCytarabine
71288-109CytarabineCytarabine
71288-168CytarabineCytarabine
71288-169CytarabineCytarabine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.